Cells of Origin in the Embryonic Nerve Roots for NF1-Associated Plexiform Neurofibroma

Cancer Cell

Volumn 26, Issue 5, 2014, Pages 695-706

  Chen, Zhiguo ^a   Liu, Chiachi ^a   Patel, Amish J ^a,b   Liao, Chung Ping ^a   Wang, Yong ^a   Le, Lu Q ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN; NEUROMODULIN; PLP1 PROTEIN, MOUSE; PROTEOLIPID PROTEIN;

ARTICLE; CELL LINEAGE; DRUG SCREENING; HUMAN; NERVE PLEXUS; NERVE ROOT; NEUROFIBROMA; NONHUMAN; PHENOTYPE; SCHWANN CELL; ANIMAL; ANIMAL EMBRYO; CARCINOGENESIS; DISEASE MODEL; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PERIPHERAL NERVE TUMOR; SPINAL GANGLION; TRANSGENIC MOUSE;

ANIMALS; CARCINOGENESIS; CELL LINEAGE; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; GANGLIA, SPINAL; GAP-43 PROTEIN; MICE, TRANSGENIC; MYELIN PROTEOLIPID PROTEIN; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMIN 1; PERIPHERAL NERVOUS SYSTEM NEOPLASMS;

EID: 84912093164     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2014.09.009     Document Type: Article

References (52)

1. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., Alvarez-Buylla A., Parada L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56.
2. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990, 63:851-859.
3. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
4. Bonnet D., Dick J.E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 1997, 3:730-737.
5. Chang T., Krisman K., Theobald E.H., Xu J., Akutagawa J., Lauchle J.O., Kogan S., Braun B.S., Shannon K. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice. J.Clin. Invest. 2013, 123:335-339.
6. Chau V., Lim S.K., Mo W., Liu C., Patel A.J., McKay R.M., Wei S., Posner B.A., De Brabander J.K., Williams N.S., et al. Preclinical therapeutic efficacy of a novel pharmacologic inducer of apoptosis in malignant peripheral nerve sheath tumors. Cancer Res. 2014, 74:586-597.
7. Chen J., Kwon C.H., Lin L., Li Y., Parada L.F. Inducible site-specificrecombination in neural stem/progenitor cells. Genesis 2009, 47:122-131.
8. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
9. Chen Z., Pradhan S., Liu C., Le L.Q. Skin-derived precursors as a source of progenitors for cutaneous nerve regeneration. Stem Cells 2012, 30:2261-2270.
10. Cichowski K., Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell 2001, 104:593-604.
11. Cichowski K., Shih T.S., Schmitt E., Santiago S., Reilly K., McLaughlin M.E., Bronson R.T., Jacks T. Mouse models of tumor development in neurofibromatosis type 1. Science 1999, 286:2172-2176.
12. Coulpier F., Le Crom S., Maro G.S., Manent J., Giovannini M., Maciorowski Z., Fischer A., Gessler M., Charnay P., Topilko P. Novel features of boundary cap cells revealed by the analysis of newly identified molecular markers. Glia 2009, 57:1450-1457.
13. Evans D.G., Baser M.E., McGaughran J., Sharif S., Howard E., Moran A. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J.Med. Genet. 2002, 39:311-314.
14. Ferner R.E. Neurofibromatosis 1. Eur. J. Hum. Genet. 2007, 15:131-138.
15. Goldstein A.S., Huang J., Guo C., Garraway I.P., Witte O.N. Identification of a cell of origin for human prostate cancer. Science 2010, 329:568-571.
16. Hall A.K. Rodent sensory neuron culture and analysis. Curr. Protoc. Neurosci. 2006, Chapter 3. Unit 3.19.
17. Hjerling-Leffler J., Marmigère F., Heglind M., Cederberg A., Koltzenburg M., Enerbäck S., Ernfors P. The boundary cap: a source of neural crest stem cells that generate multiple sensory neuron subtypes. Development 2005, 132:2623-2632.
18. Jessen K.R., Mirsky R. The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 2005, 6:671-682.
19. Jessen W.J., Miller S.J., Jousma E., Wu J., Rizvi T.A., Brundage M.E., Eaves D., Widemann B., Kim M.O., Dombi E., et al. MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. J.Clin. Invest. 2013, 123:340-347.
20. Jett K., Friedman J.M. Clinical and genetic aspects of neurofibromatosis 1. Genet. Med. 2010, 12:1-11.
21. Joseph N.M., Mosher J.T., Buchstaller J., Snider P., McKeever P.E., Lim M., Conway S.J., Parada L.F., Zhu Y., Morrison S.J. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 2008, 13:129-140.
22. Kalcheim C., Rohrer H. Neuroscience. Following the same nerve track toward different cell fates. Science 2014, 345:32-33.
23. Le L.Q., Parada L.F. Tumor microenvironment and neurofibromatosis type I: connecting the GAPs. Oncogene 2007, 26:4609-4616.
24. Le L.Q., Shipman T., Burns D.K., Parada L.F. Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 2009, 4:453-463.
25. Le L.Q., Liu C., Shipman T., Chen Z., Suter U., Parada L.F. Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development. Cancer Res. 2011, 71:4686-4695.
26. Leone D.P., Genoud S., Atanasoski S., Grausenburger R., Berger P., Metzger D., Macklin W.B., Chambon P., Suter U. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells. Mol. Cell. Neurosci. 2003, 22:430-440.
27. Li Y., Li Y., McKay R.M., Riethmacher D., Parada L.F. Neurofibromin modulates adult hippocampal neurogenesis and behavioral effects of antidepressants. J.Neurosci. 2012, 32:3529-3539.
28. Limpert A.S., Bai S., Narayan M., Wu J., Yoon S.O., Carter B.D., Lu Q.R. NF-kappaB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J.Neurosci. 2013, 33:2388-2397.
29. Lush M.E., Li Y., Kwon C.H., Chen J., Parada L.F. Neurofibromin is required for barrel formation in the mouse somatosensory cortex. J.Neurosci. 2008, 28:1580-1587.
30. Mayes D.A., Rizvi T.A., Cancelas J.A., Kolasinski N.T., Ciraolo G.M., Stemmer-Rachamimov A.O., Ratner N. Perinatal or adult Nf1 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation. Cancer Res. 2011, 71:4675-4685.
31. Parmantier E., Lynn B., Lawson D., Turmaine M., Namini S.S., Chakrabarti L., McMahon A.P., Jessen K.R., Mirsky R. Schwann cell-derived Desert hedgehog controls the development of peripheral nerve sheaths. Neuron 1999, 23:713-724.
32. Patel A.J., Liao C.P., Chen Z., Liu C., Wang Y., Le L.Q. BET bromodomain inhibition triggers apoptosis of NF1-associated malignant peripheral nerve sheath tumors through Bim induction. Cell Reports 2014, 6:81-92.
33. Ratner N., Williams J.P., Kordich J.J., Kim H.A. Schwann cell preparation from single mouse embryos: analyses of neurofibromin function in Schwann cells. Methods Enzymol. 2006, 407:22-33.
34. Reya T., Morrison S.J., Clarke M.F., Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111.
35. Robinson S.P., Langan-Fahey S.M., Johnson D.A., Jordan V.C. Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab. Dispos. 1991, 19:36-43.
36. Rubin J.B., Gutmann D.H. Neurofibromatosis type 1-a model for nervous system tumour formation?. Nat. Rev. Cancer 2005, 5:557-564.
37. Shannon K.M., O'Connell P., Martin G.A., Paderanga D., Olson K., Dinndorf P., McCormick F. Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N.Engl. J. Med. 1994, 330:597-601.
38. Staser K., Park S.J., Rhodes S.D., Zeng Y., He Y.Z., Shew M.A., Gehlhausen J.R., Cerabona D., Menon K., Chen S., et al. Normal hematopoiesis and neurofibromin-deficient myeloproliferative disease require Erk. J.Clin. Invest. 2013, 123:329-334.
39. Tonsgard J.H., Kwak S.M., Short M.P., Dachman A.H. CT imaging in adults with neurofibromatosis-1: frequent asymptomatic plexiform lesions. Neurology 1998, 50:1755-1760.
40. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
41. Tysnes B.B. Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia 2010, 12:506-515.
42. Vogel K.S., Klesse L.J., Velasco-Miguel S., Meyers K., Rushing E.J., Parada L.F. Mouse tumor model for neurofibromatosis type 1. Science 1999, 286:2176-2179.
43. Wang Y., Kim E., Wang X., Novitch B.G., Yoshikawa K., Chang L.S., Zhu Y. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities. Cell 2012, 150:816-830.
44. Ward B.A., Gutmann D.H. Neurofibromatosis 1: from lab bench to clinic. Pediatr. Neurol. 2005, 32:221-228.
45. Williams J.P., Wu J., Johansson G., Rizvi T.A., Miller S.C., Geiger H., Malik P., Li W., Mukouyama Y.S., Cancelas J.A., Ratner N. Nf1 mutation expands an EGFR-dependent peripheral nerve progenitor that confers neurofibroma tumorigenic potential. Cell Stem Cell 2008, 3:658-669.
46. Woodhoo A., Sommer L. Development of the Schwann cell lineage: from the neural crest to the myelinated nerve. Glia 2008, 56:1481-1490.
47. Wu J., Williams J.P., Rizvi T.A., Kordich J.J., Witte D., Meijer D., Stemmer-Rachamimov A.O., Cancelas J.A., Ratner N. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 2008, 13:105-116.
48. Xu G.F., O'Connell P., Viskochil D., Cawthon R., Robertson M., Culver M., Dunn D., Stevens J., Gesteland R., White R., et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990, 62:599-608.
49. Yang F.C., Ingram D.A., Chen S., Zhu Y., Yuan J., Li X., Yang X., Knowles S., Horn W., Li Y., et al. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 2008, 135:437-448.
50. Zheng H., Chang L., Patel N., Yang J., Lowe L., Burns D.K., Zhu Y. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Cancer Cell 2008, 13:117-128.
51. Zhu Y., Romero M.I., Ghosh P., Ye Z., Charnay P., Rushing E.J., Marth J.D., Parada L.F. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev. 2001, 15:859-876.
52. Zhu Y., Ghosh P., Charnay P., Burns D.K., Parada L.F. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002, 296:920-922.